Cancer Diagnostics Market Worth $26.6 Billion by 2026 – Growing Focus on Personalized Medicine and Leading Key Players
In 2020, Roche Diagnostics entered into partnership with Illumina to provide broad access to clinical oncology next-generation sequencing.
View full press release